Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Rhamnosus GG for PPI-Induced Gut Dysbiosis
NCT05517928Recruiting
- Sponsor
- Mayo Clinic
- Start
- Mar 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in intestinal dysbiosis (2 arms), sponsored by Mayo Clinic. Primary endpoint: Observed Operational Taxonomic Unit diversity at Day 56. Started Mar 2023; status: recruiting.
02
Conditions
intestinal dysbiosis
Beyond the preview
Go deeper on NCT05517928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517928.